Literature DB >> 19924149

Inflammation: where is the SPARC in adipose-tissue inflammation?

Mourad Naïmi, Emmanuel Van Obberghen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19924149     DOI： 10.1038/nrendo.2009.220

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  Inhibition of adipogenesis by Wnt signaling.

Authors:  S E Ross; N Hemati; K A Longo; C N Bennett; P C Lucas; R L Erickson; O A MacDougald
Journal:  Science       Date:  2000-08-11       Impact factor: 47.728

Review 2.  Acquired and inherited lipodystrophies.

Authors:  Abhimanyu Garg
Journal:  N Engl J Med       Date:  2004-03-18       Impact factor: 91.245

3.  Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI.

Authors:  Tayeba Khan; Eric S Muise; Puneeth Iyengar; Zhao V Wang; Manisha Chandalia; Nicola Abate; Bei B Zhang; Paolo Bonaldo; Streamson Chua; Philipp E Scherer
Journal:  Mol Cell Biol       Date:  2008-12-29       Impact factor: 4.272

4.  T-ing up inflammation in fat.

Authors:  Carey N Lumeng; Ivan Maillard; Alan R Saltiel
Journal:  Nat Med       Date:  2009-08       Impact factor: 53.440

5.  The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity.

Authors:  S Tartare-Deckert; C Chavey; M N Monthouel; N Gautier; E Van Obberghen
Journal:  J Biol Chem       Date:  2001-04-09       Impact factor: 5.157

6.  Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC.

Authors:  Julia Kzhyshkowska; Gail Workman; Marina Cardó-Vila; Wadih Arap; Renata Pasqualini; Alexei Gratchev; Liis Krusell; Sergij Goerdt; E Helene Sage
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

7.  Obesity-associated improvements in metabolic profile through expansion of adipose tissue.

Authors:  Ja-Young Kim; Esther van de Wall; Mathieu Laplante; Anthony Azzara; Maria E Trujillo; Susanna M Hofmann; Todd Schraw; Jorge L Durand; Hua Li; Guangyu Li; Linda A Jelicks; Mark F Mehler; David Y Hui; Yves Deshaies; Gerald I Shulman; Gary J Schwartz; Philipp E Scherer
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

8.  SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling.

Authors:  Jing Nie; E Helene Sage
Journal:  J Biol Chem       Date:  2008-11-05       Impact factor: 5.157

9.  SPARC-null mice exhibit increased adiposity without significant differences in overall body weight.

Authors:  A D Bradshaw; D C Graves; K Motamed; E H Sage
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

10.  Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose.

Authors:  Katrina Kos; Steve Wong; Bee Tan; Anders Gummesson; Margareta Jernas; Niclas Franck; David Kerrigan; Fredrik H Nystrom; Lena M S Carlsson; Harpal S Randeva; Jonathan H Pinkney; John P H Wilding
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461
  10 in total
  1 in total

Review 1.  SPARC: a key player in the pathologies associated with obesity and diabetes.

Authors:  Katarina Kos; John P H Wilding
Journal:  Nat Rev Endocrinol       Date:  2010-03-02       Impact factor: 43.330
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.